Noguchi Memorial Institute for Medical Research
16
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
12.5%
2 terminated/withdrawn out of 16 trials
84.6%
-1.9% vs industry average
25%
4 trials in Phase 3/4
27%
3 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana
Role: lead
Strengthening HPV Immunization Through EPI Leveraged Delivery
Role: collaborator
Impact of Malaria Mass Drug Administration on Malaria Prevalence in Under 15 Children and Pregnant Women
Role: lead
Evaluation of a LAMP Assay for T. Pallidum. Pertenue
Role: collaborator
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
Role: collaborator
Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
Role: lead
Supplementation Trial of KOKO Plus Among HIV Exposed Children in Accra
Role: lead
Twice Yearly Treatment for the Control of LF
Role: lead
Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children
Role: lead
Comparison of Two Different Doses of Azithromycin for Treatment of Yaws
Role: collaborator
Prevalence of LF Infection in Districts Not Included in LF Control Activities
Role: lead
A Phase Ib Study of NVX-508 in Sickle Cell Disease
Role: collaborator
Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana
Role: collaborator
The Effect of Malaria on Disease Progression of HIV/AIDS
Role: collaborator
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
Role: collaborator
Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study
Role: collaborator
All 16 trials loaded